Kotula; Jonathan W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kotula; Jonathan W..The latest application filed is for "bacteria engineered to treat metabolic diseases".

Company Profile

15.12.34

Kotula; Jonathan W. - Berkeley CA
Kotula; Jonathan W. - Somerville MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bacteria engineered to treat liver disease Grant 11,439,673 - Miller , et al. September 13, 2	2022-09-13
Bacteria Engineered To Treat Metabolic Diseases App 20220226395 - Falb; Dean ; et al.	2022-07-21
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier Grant 11,384,359 - Falb , et al. July 12, 2	2022-07-12
Bacteria Engineered To Treat Disorders Involving The Catabolism Of A Branched Chain Amino Acid App 20220168362 - Falb; Dean ; et al.	2022-06-02
Bacteria engineered to treat metabolic diseases Grant 11,291,693 - Falb , et al. April 5, 2	2022-04-05
Bacteria engineered to treat diseases associated with hyperammonemia Grant 11,060,073 - Falb , et al. July 13, 2	2021-07-13
Bacteria Engineered To Treat Diseases Associated With Hyperammonemia App 20210180033 - Falb; Dean ; et al.	2021-06-17
Bacteria Engineered To Treat A Disease Or Disorder App 20210169942 - Falb; Dean ; et al.	2021-06-10
Bacteria Engineered To Treat Diseases That Benefit From Reduced Gut Inflammation And/or Tightened Gut Mucosal Barrier App 20210161976 - Miller; Paul F. ; et al.	2021-06-03
Bacteria Engineered To Treat Liver Disease App 20210154243 - Miller; Paul F. ; et al.	2021-05-27
Engineered Bacteria Expressing Racemase For Treating Diseases Associated With Hyperammonemia App 20210130806 - Millet; Yves ; et al.	2021-05-06
Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier App 20210095297 - Falb; Dean ; et al.	2021-04-01
Bacteria engineered to treat a disease or disorder Grant 10,933,102 - Falb , et al. March 2, 2	2021-03-02
Bacteria Engineered to Reduce Hyperphenylalaninemia App 20200246394 - Kind Code	2020-08-06
Bacteria For The Treatment Of Disorders App 20200172857 - Falb; Dean ; et al.	2020-06-04
Bacteria engineered to reduce hyperphenylalaninemia Grant 10,610,546 - Falb , et al.	2020-04-07
Bacteria Engineered to Treat Diseases Associated with Hyperammonemia App 20190359954 - Falb; Dean ; et al.	2019-11-28
Microorganisms Programmed To Produce Immune Modulators And Anti-cancer Therapeutics In Tumor Cells App 20190336544 - Falb; Dean ; et al.	2019-11-07
Bacteria Engineered To Treat Metabolic Diseases App 20190298779 - FALB; Dean ; et al.	2019-10-03
Recombinant Bacteria Engineered To Treat Diseases And Disorders Associated With Amino Acid Metabolism And Methods Of Use Thereof App 20190282628 - Falb; Dean ; et al.	2019-09-19
Microorganisms Programmed To Produce Immune Modulators And Anti-cancer Therapeutics In Tumor Cells App 20190160115 - Falb; Dean ; et al.	2019-05-30
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier Grant 10,273,489 - Falb , et al.	2019-04-30
Bacteria engineered to reduce hyperphenylalaninemia Grant 10,195,234 - Falb , et al. Fe	2019-02-05
Bacteria Engineered To Treat Metabolic Diseases App 20190010506 - Falb; Dean ; et al.	2019-01-10
Bacteria Engineered To Reduce Hyperphenylalaninemia App 20180320161 - Falb; Dean ; et al.	2018-11-08
Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tightened Gut Mucosal Barrier App 20180312851 - Falb; Dean ; et al.	2018-11-01
Bacteria Engineered To Treat A Disease Or Disorder App 20180280451 - Falb; Dean ; et al.	2018-10-04
Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier App 20180273956 - Falb; Dean ; et al.	2018-09-27
Bacteria Engineered To Treat A Disease Or Disorder App 20180169154 - Falb; Dean ; et al.	2018-06-21
Bacteria engineered to reduce hyperphenylalaninemia Grant 9,943,555 - Falb , et al. April 17, 2	2018-04-17
Bacteria engineered to treat a disease or disorder Grant 9,889,164 - Falb , et al. February 13, 2	2018-02-13
Bacteria Engineered To Reduce Hyperphenylalaninemia App 20170312320 - Falb; Dean ; et al.	2017-11-02
Bacteria Engineered to Treat Diseases Associated with Hyperammonemia App 20170253862 - Falb; Dean ; et al.	2017-09-07
Bacteria Engineered To Treat Disorders Involving The Catabolism Of A Branched Chain Amino Acid App 20170232043 - Falb; Dean ; et al.	2017-08-17
Bacteria Engineered To Treat Disorders Involving Propionate Catabolism App 20170216370 - Falb; Dean ; et al.	2017-08-03
Bacteria engineered to treat diseases associated with hyperammonemia Grant 9,688,967 - Falb , et al. June 27, 2	2017-06-27
Bacteria Engineered to Treat Diseases Associated with Hyperammonemia App 20170137789 - Falb; Dean ; et al.	2017-05-18
Bacteria Engineered To Treat A Disease Or Disorder App 20170136073 - Falb; Dean ; et al.	2017-05-18
Bacteria Engineered To Treat Diseases That Benefit From Reduced Gut Inflammation And/or Tightened Gut Mucosal Barrier App 20170128499 - Falb; Dean ; et al.	2017-05-11
Bacteria Engineered To Treat Diseases That Benefit From Reduced Gut Inflammation And/or Tightened Gut Mucosal Barrier App 20170067065 - Falb; Dean ; et al.	2017-03-09
Bacteria Engineered to Reduce Hyperphenylalaninemia App 20170014457 - Falb; Dean ; et al.	2017-01-19
Bacteria Engineered to Reduce Hyperphenylalaninemia App 20160340665 - Falb; Dean ; et al.	2016-11-24
Bacteria Engineered to Treat Diseases Associated with Hyperammonemia App 20160333326 - Falb; Dean ; et al.	2016-11-17
Bacteria engineered to treat diseases associated with hyperammonemia Grant 9,487,764 - Falb , et al. November 8, 2	2016-11-08
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier App 20160206666 - Falb; Dean ; et al.	2016-07-21
Bacteria Engineered to Treat Diseases Associated with Hyperammonemia App 20160177274 - Falb; Dean ; et al.	2016-06-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.